184 related articles for article (PubMed ID: 38398153)
1. Human GST P1-1 Redesigned for Enhanced Catalytic Activity with the Anticancer Prodrug Telcyta and Improved Thermostability.
Ismail A; Govindarajan S; Mannervik B
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398153
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of glutathione transferase P1-1-catalyzed activation of the prodrug canfosfamide (TLK286, TELCYTA).
Dourado DF; Fernandes PA; Ramos MJ; Mannervik B
Biochemistry; 2013 Nov; 52(45):8069-78. PubMed ID: 24066958
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Dog Glutathione Transferase P1-1, an Enzyme Relevant to Veterinary Medicine.
Ismail A; Lewis E; Sjödin B; Mannervik B
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920860
[TBL] [Abstract][Full Text] [Related]
4. Human glutathione transferases catalyzing the bioactivation of anticancer thiopurine prodrugs.
Eklund BI; Gunnarsdottir S; Elfarra AA; Mannervik B
Biochem Pharmacol; 2007 Jun; 73(11):1829-41. PubMed ID: 17433263
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 2-substituted-5-(4-nitrophenylsulfonamido)benzoxazoles as human GST P1-1 inhibitors, and description of the binding site features.
Ertan-Bolelli T; Musdal Y; Bolelli K; Yilmaz S; Aksoy Y; Yildiz I; Aki-Yalcin E; Yalcin I
ChemMedChem; 2014 May; 9(5):984-92. PubMed ID: 24677708
[TBL] [Abstract][Full Text] [Related]
6. Chemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer Cells.
van Gisbergen MW; Cebula M; Zhang J; Ottosson-Wadlund A; Dubois L; Lambin P; Tew KD; Townsend DM; Haenen GR; Drittij-Reijnders MJ; Saneyoshi H; Araki M; Shishido Y; Ito Y; Arnér ES; Abe H; Morgenstern R; Johansson K
Mol Pharm; 2016 Jun; 13(6):2010-25. PubMed ID: 27093577
[TBL] [Abstract][Full Text] [Related]
7. FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1.
Musdal Y; Hegazy UM; Aksoy Y; Mannervik B
Chem Biol Interact; 2013 Sep; 205(1):53-62. PubMed ID: 23769903
[TBL] [Abstract][Full Text] [Related]
8. Glutathione transferases in the bioactivation of azathioprine.
Modén O; Mannervik B
Adv Cancer Res; 2014; 122():199-244. PubMed ID: 24974183
[TBL] [Abstract][Full Text] [Related]
9. Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases.
Berhane K; Widersten M; Engström A; Kozarich JW; Mannervik B
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1480-4. PubMed ID: 8108434
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cellular enzymes by equine catechol estrogens in human breast cancer cells: specificity for glutathione S-transferase P1-1.
Yao J; Chang M; Li Y; Pisha E; Liu X; Yao D; Elguindi EC; Blond SY; Bolton JL
Chem Res Toxicol; 2002 Jul; 15(7):935-42. PubMed ID: 12119004
[TBL] [Abstract][Full Text] [Related]
11. Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT).
Biela BH; Khawli LA; Hu P; Epstein AL
Cancer Biother Radiopharm; 2003 Jun; 18(3):339-53. PubMed ID: 12954121
[TBL] [Abstract][Full Text] [Related]
12. Prodrugs in cancer chemotherapy.
Connors TA; Knox RJ
Stem Cells; 1995 Sep; 13(5):501-11. PubMed ID: 8528099
[TBL] [Abstract][Full Text] [Related]
13. The human glutathione transferase P1-1 specific inhibitor TER 117 designed for overcoming cytostatic-drug resistance is also a strong inhibitor of glyoxalase I.
Johansson AS; Ridderström M; Mannervik B
Mol Pharmacol; 2000 Mar; 57(3):619-24. PubMed ID: 10692504
[TBL] [Abstract][Full Text] [Related]
14. Toward antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1 and novel in vivo stable prodrugs of methotrexate.
Smith GK; Banks S; Blumenkopf TA; Cory M; Humphreys J; Laethem RM; Miller J; Moxham CP; Mullin R; Ray PH; Walton LM; Wolfe LA
J Biol Chem; 1997 Jun; 272(25):15804-16. PubMed ID: 9188478
[TBL] [Abstract][Full Text] [Related]
15. Selective induction of the tumor marker glutathione S-transferase P1 by proteasome inhibitors.
Usami H; Kusano Y; Kumagai T; Osada S; Itoh K; Kobayashi A; Yamamoto M; Uchida K
J Biol Chem; 2005 Jul; 280(26):25267-76. PubMed ID: 15863507
[TBL] [Abstract][Full Text] [Related]
16. Emergence of a novel highly specific and catalytically efficient enzyme from a naturally promiscuous glutathione transferase.
Blikstad C; Shokeer A; Kurtovic S; Mannervik B
Biochim Biophys Acta; 2008 Dec; 1780(12):1458-63. PubMed ID: 18706975
[TBL] [Abstract][Full Text] [Related]
17. Modulation of GST P1-1 activity by polymerization during apoptosis.
Bernardini S; Bernassola F; Cortese C; Ballerini S; Melino G; Motti C; Bellincampi L; Iori R; Federici G
J Cell Biochem; 2000 Apr; 77(4):645-53. PubMed ID: 10771520
[TBL] [Abstract][Full Text] [Related]
18. Antibody-directed enzyme prodrug therapy (ADEPT): a review.
Springer CJ; Niculescu-Duvaz I
Adv Drug Deliv Rev; 1997 Jul; 26(2-3):151-172. PubMed ID: 10837540
[TBL] [Abstract][Full Text] [Related]
19. Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer.
Kavanagh JJ; Gershenson DM; Choi H; Lewis L; Patel K; Brown GL; Garcia A; Spriggs DR
Int J Gynecol Cancer; 2005; 15(4):593-600. PubMed ID: 16014111
[TBL] [Abstract][Full Text] [Related]
20. Extract of Ginkgo biloba induces glutathione-S-transferase subunit-P1 in vitro.
Liu XP; Goldring CE; Wang HY; Copple IM; Kitteringham NR; Park BK
Phytomedicine; 2009 May; 16(5):451-5. PubMed ID: 19131229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
